The high proportions of luminal A (42.9%) and luminal B (31.1%) subtype were observed in the age group 41-50 years, whereas high proportions of HER2/neu type (32.8%) and triple-negative (35.8%) breast cancer were observed in the age group 31-40 years. The gene discussed is ERBB2; the disease is breast carcinoma.